Loading...
Bienvenue sur la collection HAL du laboratoire de BECCOH
Quelques conseils pour une publication "idéHALe"
• Pensez à respecter la signature institutionnelle
Université Paris-Saclay, UVSQ, BECCOH, 92104, Boulogne-Billancourt, France..
• Participez à l'accès ouvert
N'attendez pas : dès que votre article est en ligne, déposez dans Hal sa version acceptée pour publication et indiquez un embargo de 6 mois.
La loi pour une république numérique vous autorise en effet à partager cette version 6 mois après publications, quelque-soit l'éditeur
Plus d'informations Archives Ouverte : quid de mes droits d'auteurs ?
• Vous souhaitez disposer d'une page web référençant toutes vos publications ?
Créez vous en 5 minutes un idHal et un CVHAL
N'hésitez pas à nous contacter pour toutes questions,
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
Dernières Publications en accès ouvert dans Hal
-
Paul Takam Kamga, Marie Mayenga, Louise Sebane, Adrien Costantini, Catherine Julie, et al.. Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer, 2024, 188, pp.107447. ⟨10.1016/j.lungcan.2023.107447⟩. ⟨hal-04517531⟩
-
Robin Zagala, Nicolas Meyer, Philippe Saiag, Nora Kramkimel, Celeste Lebbe, et al.. Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network. Journal of the European Academy of Dermatology and Venereology, In press, ⟨10.1111/jdv.20155⟩. ⟨hal-04626767⟩
-
Alexander Stratigos, Claus Garbe, Clio Dessinioti, Celeste Lebbe, Alexander van Akkooi, et al.. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023. European Journal of Cancer, 2023, 193, pp.113252. ⟨10.1016/j.ejca.2023.113252⟩. ⟨inserm-04209605⟩
-
Alexander Stratigos, Claus Garbe, Clio Dessinioti, Celeste Lebbe, Alexander van Akkooi, et al.. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023. European Journal of Cancer, 2023, 193, pp.113251. ⟨10.1016/j.ejca.2023.113251⟩. ⟨inserm-04210036⟩
-
Julien Taïeb, Olivier Bouche, Thierry André, Karine Le Malicot, Pierre Laurent-Puig, et al.. Avelumab vs Standard Second-Line Chemotherapy in Patients with Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial. JAMA oncology, 2023, 9 (10), ⟨10.1001/jamaoncol.2023.2761⟩. ⟨hal-04322943⟩
Mots clés
ACTH
Nivolumab
Children
Polyomavirus
Adverse events
Advanced
ALK
Abscopal effect colorectal cancer intratumoral immunotherapy liver metastases radiofrequency
Treatment
Anti-PD1 blockade
Non-small cell lung cancer
Adjuvant therapy
Survival
Histiocytosis
Staging
Sonic Hedgehog
Bariatric surgery
Follow-up
Mesenchymal stromal cells
Abscopal effect anti-PD-1 antibody melanoma nivolumab pembrolizumab radiotherapy
Cancer bronchique non à petites cellules
2-chlorodeoxyadenosine
BRAFV600-mutant melanoma
Plasma
Immune checkpoint inhibitor
Adjuvant FOLFOX
Body mass index
Adapted physical activity molecular diagnosis oligometastatic disease pancreatic adenocarcinoma KRAS mutation
Immunohistochemistry
Beta-catenin
Cancer
Prognostic
Colorectal cancer
Biomarkers
Anti-CTLA-4
Biomarkers Colonic neoplasms Machine learning Prognosis Tumour infiltrating lymphocytes
TNM classification
Prognosis
Anti-PD-1
Targeted therapy
BRAF V600E
Safety
Colorectal carcinoma
Anti-Tumor pharmacology
Chemotherapy
Prevention
Assisted reproductive techniques
Systemic therapy
Merkel cell carcinoma
Anti-PD1
Bisphosphonates
Resistance
Chemoresistance
Crizotinib
Adjuvant
Antineoplastic agents
Immunotherapy
Langerhans cell histiocytosis
Abdominal pain
Biomarker
Circulating tumor DNA
Antibody-drug conjugate
BRAF
Biliopancreatic diversion
Lung adenocarcinoma
Trametinib
Invasive cutaneous squamous cell carcinoma
BRAF V600-mutation
Diagnosis
Metastatic
BRAFV600E mutation
Circulating cell-free DNA
BRAFV600E
Gastric bypass
Cutaneous squamous cell carcinoma
Acute generalized exanthematous pustulosis
EGFR
Anti-CTLA-4 anti-PD-1 elderly immune checkpoint inhibitors melanoma nonagenarian octogenarian
AML
Radiotherapy
Allelic imbalance
Cemiplimab
Immunomodulation
Molecular targeted therapies
Radiofrequency ablation
Anti-PD-1 antibody
Colon cancer
Locally advanced
Dabrafenib
ALK rearrangement
Androgen insensitivity
Osimertinib
Wnt
Metastatic cSCC
Abscopal effect
AZD9291
Advanced melanoma
ADN tumoral circulant
Melanoma
Surgical excision